Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe.

[1]  M. D. Granado,et al.  WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update , 2011, European Respiratory Journal.

[2]  Stefan Niemann,et al.  Evaluation and Strategy for Use of MIRU-VNTRplus, a Multifunctional Database for Online Analysis of Genotyping Data and Phylogenetic Identification of Mycobacterium tuberculosis Complex Isolates , 2008, Journal of Clinical Microbiology.

[3]  A. W. Sturm,et al.  Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. , 2007, Clinical Infectious Diseases.

[4]  S. Niemann,et al.  Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  D. van Soolingen,et al.  Genotype and phenotype relationships and transmission analysis of drug-resistant tuberculosis in Singapore. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[6]  G. Orefici,et al.  Usefulness of the BACTEC MGIT 960 System for Isolation of Mycobacterium tuberculosis from Sputa Subjected to Long-Term Storage , 2006, Journal of Clinical Microbiology.

[7]  S. Dubiley,et al.  Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. , 2006, Journal of medical microbiology.

[8]  Mehran Hosseini,et al.  Global incidence of multidrug-resistant tuberculosis. , 2006, The Journal of infectious diseases.

[9]  Leen Rigouts,et al.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology , 2006, BMC Microbiology.

[10]  V. Leimane,et al.  Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[11]  S. Niemann,et al.  The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia , 2005, Respiratory research.

[12]  France,et al.  Does one size fit all? Drug resistance and standard treatments: results of six tuberculosis programmes in former Soviet countries. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  Y. Balabanova,et al.  Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. , 2005, JAMA.

[14]  G. Orefici,et al.  Mycobacterium tuberculosis Drug Resistance, Abkhazia , 2005, Emerging infectious diseases.

[15]  T. Shinnick,et al.  Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[16]  S. Niemann,et al.  The Beijing genotype is emerging among multidrug-resistant Mycobacterium tuberculosis strains from Germany. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  D. Falzon,et al.  Multidrug-resistant Tuberculosis in Central Asia , 2004, Emerging infectious diseases.

[18]  D. van Soolingen,et al.  Worldwide Occurrence of Beijing/W Strains of Mycobacterium tuberculosis: A Systematic Review , 2002, Emerging infectious diseases.

[19]  D. Wilkinson.  Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .

[20]  D van Soolingen,et al.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology , 1997, Journal of clinical microbiology.

[21]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[22]  P. Escalante.  Tuberculosis , 1904, Annals of Internal Medicine.

[23]  T. Mexia,et al.  Author ' s personal copy , 2009 .

[24]  Barun Mathema,et al.  Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. , 2002, Trends in microbiology.

[25]  C. Dye,et al.  Anti-tuberculosis drug resistance in the world: The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Geneva: World Health Organization, 1997. 228pp. Price Sw. fr 25/US$22.50 (in developing countries Sw. fir 17.50). (Reference WHO/TB/97.229) , 1998 .